Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim

Published:2020-07-07 Issue:17 Volume:9 Page:6102-6110
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Kang Ka‐Won¹^ORCID,Lee Byung‐Hyun¹^ORCID,Jeon Min Ji¹,Yu Eun Sang¹,Kim Dae Sik¹,Lee Se Ryeon¹,Sung Hwa Jung¹,Choi Chul Won¹,Park Yong¹,Kim Byung Soo¹

Affiliation:

1. Division of Hematology‐Oncology Department of Internal Medicine Korea University College of Medicine Seoul South Korea

Funder

Korea Health Industry Development Institute

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3261

Reference36 articles.

1. Management of chemotherapy-associated febrile neutropenia

2. A Patient Risk Model of Chemotherapy-Induced Febrile Neutropenia: Lessons Learned From the ANC Study Group

3. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

4. G‐CSF: function and modes of action (Review);Basu S;Int J Mol Med,2002

5. Molecular analysis of the granulocyte colony-stimulating factor receptor

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Originator and Biosimilar G-CSF as Primary Prophylaxis in DLBCL: A Cohort Study and Meta-Analysis;2023-09-11

2. G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review;Expert Review of Hematology;2022-07-03

3. Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience;BioDrugs;2022-05

4. Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy;Journal of Chemotherapy;2021-12-06

5. Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2021-10-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3